July 27 2005 – Purepoint Uranium Group Inc. (TSX-V:PTU) has announced today the appointment of James Doak to the Board of Directors.
“On behalf of all of us at Purepoint, we’re very pleased to have Jim on the Board,” said Chris Frostad, President and CEO, Purepoint Uranium Group Inc. “He brings a great depth of knowledge in the financial services industry to the group.”
Doak, an Economist and Chartered Financial Analyst, is currently the President and Managing Director of Megantic Asset Management Inc., a Toronto-based investment company. He is also a director of PetroKazakhstan Inc., the third largest oil and gas producer in Kazakhstan and a company trading on the Toronto, New York and London stock exchanges.
A former Director of Superior Propane Inc. and Spar Aerospace Inc., Doak has also held key positions at ScotiaMcLeod Inc., First Marathon Securities Ltd., and McLeod Young Weir Ltd. Over the period between 1979 and 1997, Doak was the founder and President of Enterprise Capital Management Inc. and a past President and Director of the Toronto Society of Financial Analysts.
In addition, Doak is an active community member serving on a number of community associations. He is credited with establishing the Robert J. Salter Fellowship at the Toronto Hospital for Sick Children.
Purepoint Uranium Corporation is a uranium exploration company driven by intellectual, precision prospecting focusing on distinct, targeted properties with historic significance in the Canadian Athabasca Basin. Currently, Purepoint’s seven, 100% owned, Athabasca Basin uranium projects cover nearly 120,000 hectares and are considered high prospect properties that include several near term targets drill ready for winter 2005/06.
